2014
DOI: 10.1016/j.knee.2014.09.010
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: A meta-analysis of randomized controlled and prospective cohort trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
96
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 114 publications
(101 citation statements)
references
References 26 publications
3
96
0
2
Order By: Relevance
“…The most common metrics include total blood loss, intra-operative blood loss, post operative blood loss, drain output, hemoglobin reduction, and transfusion rates. Meta analyses comparing studies that use the same metrics for efficacy have widely determined TXA use is superior to placebo controls, however such analyses are rarely, if ever, able to compare studies using the exact same dosing regimens and so their conclusions are typically broadly applicable to the use of TXA but do not delve into the optimal IV and or topical dosing strategies other than speculation [6,7,[29][30][31].…”
Section: And Topical Usementioning
confidence: 99%
See 1 more Smart Citation
“…The most common metrics include total blood loss, intra-operative blood loss, post operative blood loss, drain output, hemoglobin reduction, and transfusion rates. Meta analyses comparing studies that use the same metrics for efficacy have widely determined TXA use is superior to placebo controls, however such analyses are rarely, if ever, able to compare studies using the exact same dosing regimens and so their conclusions are typically broadly applicable to the use of TXA but do not delve into the optimal IV and or topical dosing strategies other than speculation [6,7,[29][30][31].…”
Section: And Topical Usementioning
confidence: 99%
“…In THA and TKA, the most notable complication reported in the literature is venous thromboembolism. The vast majority of orthopaedic TXA studies show no increase in the rate of venous thromboembolism events [29][30][31]43,44]. Nishihara, et al is the only study in the recently published literature known to the authors that demonstrated a significant increase in venous thromboembolic events after TXA administration in total joint arthroplasty [18].…”
Section: Oral Usementioning
confidence: 99%
“…[25] The authors did not find any difference in the degree of postoperative blood loss, number of administered BTs and in the incidence of thromboembolic complications.…”
Section: Discussionmentioning
confidence: 85%
“…[5][6][7][8][9][10]12,13] The patients in this study received 2 g TA intraarticularly at the end of the surgery before the skin closure similar to the previous published papers [5,13] while the others did not receive any antifibrinolytics.…”
Section: Discussionmentioning
confidence: 91%
“…[4] Topical use of TA has been becoming popular recently as it has the advantages of being easy to administer, providing a maximum concentration at the bleeding site, and inducing partial microvascular hemostasis by stopping fibrin clot dissolution in the affected area. Some studies about topical administration of TA showed reliable evidence that it was effective in reducing total blood loss and blood transfusion rate compared with the placebo [5][6][7][8][9] and also intravenous (IV) administrations. Topical use of TA has been shown to reduce postoperative swelling, leading to improved wound healing, reduced pain, and more rapid rehabilitation.…”
mentioning
confidence: 99%